- Home
- AADI vs GROW Comparison
AADI vs GROW Comparison
Compare AADI & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AADI
- GROW
- Stock Information
- Founded
- AADI 2011
- GROW 1968
- Country
- AADI United States
- GROW United States
- Employees
- AADI 70
- GROW N/A
- Industry
- AADI Biotechnology: Pharmaceutical Preparations
- GROW Investment Managers
- Sector
- AADI Health Care
- GROW Finance
- Exchange
- AADI Nasdaq
- GROW Nasdaq
- Market Cap
- AADI 51.7M
- GROW 34.9M
- IPO Year
- AADI N/A
- GROW N/A
- Fundamental
- Price
- AADI $2.10
- GROW $2.43
- Analyst Decision
- AADI Hold
- GROW
- Analyst Count
- AADI 3
- GROW 0
- Target Price
- AADI $1.75
- GROW N/A
- AVG Volume (30 Days)
- AADI 102.0K
- GROW 40.5K
- Earning Date
- AADI 11-06-2024
- GROW 12-12-2024
- Dividend Yield
- AADI N/A
- GROW 3.67%
- EPS Growth
- AADI N/A
- GROW N/A
- EPS
- AADI N/A
- GROW 0.09
- Revenue
- AADI $23,817,000.00
- GROW $10,984,000.00
- Revenue This Year
- AADI $4.79
- GROW N/A
- Revenue Next Year
- AADI $10.72
- GROW N/A
- P/E Ratio
- AADI N/A
- GROW $27.33
- Revenue Growth
- AADI 10.57
- GROW N/A
- 52 Week Low
- AADI $1.21
- GROW $2.38
- 52 Week High
- AADI $5.70
- GROW $3.11
- Technical
- Relative Strength Index (RSI)
- AADI 63.80
- GROW 35.11
- Support Level
- AADI $1.90
- GROW $2.38
- Resistance Level
- AADI $2.17
- GROW $2.52
- Average True Range (ATR)
- AADI 0.09
- GROW 0.06
- MACD
- AADI 0.00
- GROW -0.00
- Stochastic Oscillator
- AADI 70.49
- GROW 25.00
About AADI Aadi Bioscience Inc.
Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.